NO314848B1 - Protein for inhibering av kollagenfremkalt blodplateaggregering, DNA som koder for proteinet, vektor som omfatter et slikt DNA, vertscelletransformert medvektoren, fremgangsmåter for fremstilling og rensing avproteinet, farmasöytiskpreparat - Google Patents

Protein for inhibering av kollagenfremkalt blodplateaggregering, DNA som koder for proteinet, vektor som omfatter et slikt DNA, vertscelletransformert medvektoren, fremgangsmåter for fremstilling og rensing avproteinet, farmasöytiskpreparat Download PDF

Info

Publication number
NO314848B1
NO314848B1 NO19940771A NO940771A NO314848B1 NO 314848 B1 NO314848 B1 NO 314848B1 NO 19940771 A NO19940771 A NO 19940771A NO 940771 A NO940771 A NO 940771A NO 314848 B1 NO314848 B1 NO 314848B1
Authority
NO
Norway
Prior art keywords
protein
seq
dna
inhibitor
sequence
Prior art date
Application number
NO19940771A
Other languages
English (en)
Norwegian (no)
Other versions
NO940771D0 (no
NO940771L (no
Inventor
Christiane Noeske-Jungblut
Bernard Jacques Haendler
Joern Reiner Kraetzschmar
Wolf-Dieter Schleuning
Alejandro Alagon
Lourival Possani
Delia Anatolia Cuevas-Aguirre
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO940771D0 publication Critical patent/NO940771D0/no
Publication of NO940771L publication Critical patent/NO940771L/no
Publication of NO314848B1 publication Critical patent/NO314848B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19940771A 1991-09-05 1994-03-04 Protein for inhibering av kollagenfremkalt blodplateaggregering, DNA som koder for proteinet, vektor som omfatter et slikt DNA, vertscelletransformert medvektoren, fremgangsmåter for fremstilling og rensing avproteinet, farmasöytiskpreparat NO314848B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75621191A 1991-09-05 1991-09-05
US81488491A 1991-12-31 1991-12-31
US91438392A 1992-07-17 1992-07-17
PCT/EP1992/002052 WO1993005150A1 (en) 1991-09-05 1992-09-04 Collagen-induced platelet aggregation inhibitor

Publications (3)

Publication Number Publication Date
NO940771D0 NO940771D0 (no) 1994-03-04
NO940771L NO940771L (no) 1994-03-04
NO314848B1 true NO314848B1 (no) 2003-06-02

Family

ID=27419489

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19940771A NO314848B1 (no) 1991-09-05 1994-03-04 Protein for inhibering av kollagenfremkalt blodplateaggregering, DNA som koder for proteinet, vektor som omfatter et slikt DNA, vertscelletransformert medvektoren, fremgangsmåter for fremstilling og rensing avproteinet, farmasöytiskpreparat

Country Status (16)

Country Link
EP (1) EP0530937B1 (de)
JP (2) JPH07506959A (de)
KR (1) KR100232683B1 (de)
AT (1) ATE169674T1 (de)
AU (1) AU672584B2 (de)
CA (1) CA2117174A1 (de)
DE (1) DE69226580T2 (de)
DK (1) DK0530937T3 (de)
ES (1) ES2121817T3 (de)
FI (1) FI112801B (de)
HU (1) HU218830B (de)
IL (4) IL103065A (de)
NO (1) NO314848B1 (de)
NZ (1) NZ244246A (de)
RU (1) RU2128705C1 (de)
WO (1) WO1993005150A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2186110C2 (ru) * 1994-09-12 2002-07-27 Шеринг Аг Рекомбинантный белок asp-паллидипин, способ его производства и очистки, вектор, штамм, фармацевтическая композиция
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
JP3837519B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のTi−3蛋白質
JP3837518B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のTi−4蛋白質
AU2003227721A1 (en) * 2003-05-02 2004-11-23 Paion Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
ATE384735T1 (de) * 2003-05-21 2008-02-15 Ares Trading Sa Verfahren zur chromatographischen analyse einer proteinlösung
EP1760092A1 (de) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System für Screening von Zellen mit hoher Expression von einem interessierenden Protein
WO2007038749A2 (en) 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
JP5332178B2 (ja) * 2007-11-02 2013-11-06 東洋紡株式会社 多色ルシフェラーゼの検出方法
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
CN109125355B (zh) * 2018-08-03 2022-07-08 昆明医科大学第一附属医院 心脉隆抗血小板及抗血栓药理应用
CN110327994B (zh) * 2019-07-11 2020-12-08 北京理工大学 一种多维微流控电泳芯片及检测装置,检测方法

Also Published As

Publication number Publication date
HU218830B (hu) 2000-12-28
DE69226580T2 (de) 1999-03-04
KR100232683B1 (ko) 1999-12-01
NO940771D0 (no) 1994-03-04
HUT70271A (en) 1995-09-28
DK0530937T3 (da) 1999-05-10
IL103065A0 (en) 1993-02-21
AU672584B2 (en) 1996-10-10
WO1993005150A1 (en) 1993-03-18
EP0530937B1 (de) 1998-08-12
RU2128705C1 (ru) 1999-04-10
RU94045930A (ru) 1996-07-20
IL119491A0 (en) 1997-01-10
DE69226580D1 (de) 1998-09-17
JP2003313199A (ja) 2003-11-06
ATE169674T1 (de) 1998-08-15
NZ244246A (en) 1994-03-25
IL103065A (en) 2001-11-25
IL119491A (en) 2000-11-21
HU9400662D0 (en) 1994-06-28
AU2502292A (en) 1993-04-05
FI112801B (fi) 2004-01-15
NO940771L (no) 1994-03-04
FI941052A0 (fi) 1994-03-04
CA2117174A1 (en) 1993-03-18
EP0530937A1 (de) 1993-03-10
FI941052A (fi) 1994-03-04
IL119492A0 (en) 1997-01-10
ES2121817T3 (es) 1998-12-16
JPH07506959A (ja) 1995-08-03

Similar Documents

Publication Publication Date Title
US5759542A (en) Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
JP3136551B2 (ja) インターロイキン1β前駆体変換酵素をコードするDNA
JP3051995B2 (ja) 酸化抵抗性トロンボモジュリン類縁体
DK176140B1 (da) Flagermusspyt-plasminogenaktivatorer
NO314848B1 (no) Protein for inhibering av kollagenfremkalt blodplateaggregering, DNA som koder for proteinet, vektor som omfatter et slikt DNA, vertscelletransformert medvektoren, fremgangsmåter for fremstilling og rensing avproteinet, farmasöytiskpreparat
RU2186110C2 (ru) Рекомбинантный белок asp-паллидипин, способ его производства и очистки, вектор, штамм, фармацевтическая композиция
AU708102B2 (en) Chimeric MCP and DAF proteins with cell surface localizing domain
US5589360A (en) Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
MXPA97001720A (en) Process for the manufacture of a modified palidipine, inhibitor of platelet aggregation induced by colag
US5756454A (en) Collagen-induced platelet aggregation inhibitor
JPH10215885A (ja) 新規lep
CA2150909A1 (en) Clotting inhibitor made from protostomia saliva
US5801017A (en) Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis
AU4581200A (en) Protease activated receptor 2 variants
JP2002125671A (ja) 新規rsbU−1
US20040091887A1 (en) Mucroslysin and its gene
JPH10337188A (ja) 新規greA